|1.||Chekir-Ghedira, Leila: 1 article (02/2015)|
|2.||Bzéouich, Imèn Mokdad: 1 article (02/2015)|
|3.||Hennebelle, Thierry: 1 article (02/2015)|
|4.||Ghedira, Kamel: 1 article (02/2015)|
|5.||Mustapha, Nadia: 1 article (02/2015)|
|6.||Li, Peng: 1 article (08/2008)|
|7.||Fu, Jian-hua: 1 article (08/2008)|
|8.||Li, Xin-zhi: 1 article (08/2008)|
|1.||Melanoma (Melanoma, Malignant)
02/01/2015 - "Poor therapeutic results have been reported for treatment of malignant melanoma; therefore in this study, we have investigated inhibitory capacity of vitexin-2''-O-rhamnoside as well as the extract from which it was isolated, i.e. "
02/01/2015 - "Ethyl acetate extract and vitexin-2''-O-rhamnoside exhibited significant anti-proliferative activity against B16F10 melanoma cells after incubation for 48hours with IC50s of 50μg/mL and 20μM, respectively. "
08/01/2008 - "To study the effect and molecular mechanism of two haw leaf extracts, Vitexin-rhamnoside (VR) and Vitexin-glucoside (VG), and their preparation, Aoshaen injection (AI), on the polymorphonuclear leucocyte (PMN) adhesion during human umbilical vein endothelial cell (HUVEC) anoxia/reoxygenation (A/R) injury. "